CN1037895A - 杂脂族羧酰胺类化合物 - Google Patents

杂脂族羧酰胺类化合物 Download PDF

Info

Publication number
CN1037895A
CN1037895A CN89102211A CN89102211A CN1037895A CN 1037895 A CN1037895 A CN 1037895A CN 89102211 A CN89102211 A CN 89102211A CN 89102211 A CN89102211 A CN 89102211A CN 1037895 A CN1037895 A CN 1037895A
Authority
CN
China
Prior art keywords
formula
compound
methyl
ylmethyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN89102211A
Other languages
English (en)
Chinese (zh)
Inventor
维克托·朱利奥·马塔萨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Americas Inc filed Critical ICI Americas Inc
Publication of CN1037895A publication Critical patent/CN1037895A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN89102211A 1988-04-14 1989-04-13 杂脂族羧酰胺类化合物 Pending CN1037895A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18133488A 1988-04-14 1988-04-14
US181334 1988-04-14

Publications (1)

Publication Number Publication Date
CN1037895A true CN1037895A (zh) 1989-12-13

Family

ID=22663845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN89102211A Pending CN1037895A (zh) 1988-04-14 1989-04-13 杂脂族羧酰胺类化合物

Country Status (23)

Country Link
EP (1) EP0337766B1 (enExample)
JP (1) JP2740250B2 (enExample)
KR (1) KR890016016A (enExample)
CN (1) CN1037895A (enExample)
AT (1) ATE86612T1 (enExample)
AU (1) AU622649B2 (enExample)
CA (1) CA1334197C (enExample)
DD (1) DD286581A5 (enExample)
DE (1) DE68905216T2 (enExample)
DK (1) DK176089A (enExample)
ES (1) ES2053983T3 (enExample)
FI (1) FI891764A7 (enExample)
GB (1) GB8906032D0 (enExample)
GR (1) GR3007302T3 (enExample)
HU (1) HUT54995A (enExample)
IE (1) IE63209B1 (enExample)
IL (1) IL89925A0 (enExample)
MW (1) MW2189A1 (enExample)
NO (1) NO891501L (enExample)
NZ (1) NZ228722A (enExample)
PT (1) PT90269B (enExample)
ZA (1) ZA892637B (enExample)
ZM (1) ZM1689A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
EP0539329A1 (de) * 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
EP0539330B1 (de) * 1991-10-25 1995-05-17 Ciba-Geigy Ag Verfahren zur Herstellung substituierter Indole
KR100436812B1 (ko) * 1995-01-06 2004-08-31 도레이 가부시끼가이샤 벤젠축합헤테로환유도체및그유도체를유효성분으로함유하는의약조성물
CA2322162A1 (en) * 1998-02-25 1999-09-02 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
TW201309670A (zh) 2011-01-25 2013-03-01 Kissei Pharmaceutical 吲哚衍生物或其藥理學上容許之鹽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides

Also Published As

Publication number Publication date
FI891764A7 (fi) 1989-10-15
FI891764A0 (fi) 1989-04-13
AU3177089A (en) 1989-10-19
PT90269B (pt) 1994-07-29
DE68905216T2 (de) 1993-06-17
HUT54995A (en) 1991-04-29
DK176089A (da) 1989-10-15
NZ228722A (en) 1991-08-27
ATE86612T1 (de) 1993-03-15
DK176089D0 (da) 1989-04-12
CA1334197C (en) 1995-01-31
ES2053983T3 (es) 1994-08-01
MW2189A1 (en) 1989-12-13
DE68905216D1 (de) 1993-04-15
EP0337766A1 (en) 1989-10-18
NO891501L (no) 1989-10-16
KR890016016A (ko) 1989-11-28
ZM1689A1 (en) 1990-01-26
IE63209B1 (en) 1995-04-05
EP0337766B1 (en) 1993-03-10
GB8906032D0 (en) 1989-04-26
GR3007302T3 (enExample) 1993-07-30
PT90269A (pt) 1989-11-10
IL89925A0 (en) 1989-12-15
AU622649B2 (en) 1992-04-16
JP2740250B2 (ja) 1998-04-15
ZA892637B (en) 1989-12-27
NO891501D0 (no) 1989-04-12
DD286581A5 (de) 1991-01-31
JPH01311063A (ja) 1989-12-15
IE891188L (en) 1989-10-14

Similar Documents

Publication Publication Date Title
CN1279023C (zh) 吲哚－3－硫衍生物
CN1234688C (zh) 3－芳酰基吲哚及其作为cb2受体激动剂的应用
CN1124262C (zh) 用作内皮缩血管肽受体拮抗剂的吲哚衍生物
CN1309384C (zh) 具有5－ht6受体亲和性的4－哌嗪基苯磺酰基吲哚
CN1061341C (zh) 1－氨基乙基吲哚衍生物
CN1036456C (zh) 氨基取代的吡唑
CN1290844C (zh) 用作蛋白激酶抑制剂的二氢吲哚酮衍生物
CN1656075A (zh) 喹啉衍生物和其作为5－ht6配体的用途
CN1906189A (zh) 用于治疗呼吸系统疾病的1－乙酸－吲哚、－吲唑和－苯并咪唑衍生物
CN1620438A (zh) 用作cbi拮抗剂的5,6－二芳基－吡嗪－2－酰胺衍生物
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1668590A (zh) 用作5－羟色胺－6配体的1－杂环基烷基－3－磺酰基－吲哚或－吲唑衍生物
CN1149051A (zh) 用作α1-肾上腺素能受体拮抗剂的嘧啶二酮、嘧啶三酮、三嗪二酮、四氢喹唑啉二酮衍生物
CN1305464A (zh) 杂环化合物和治疗心力衰竭及其它疾病的方法
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1037895A (zh) 杂脂族羧酰胺类化合物
CN87103504A (zh) 杂环羧酰胺
CN1230432C (zh) 取代的苯基－哌嗪衍生物及其制备和用途
CN1244577C (zh) 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物
CN1022322C (zh) 稠合吡唑3-氧代-丙腈衍生物的制备方法
CN1083812A (zh) 苯并咪唑类，含有这些化合物的药物组合物和它们的制备
CN1787995A (zh) 用作尿－选择性α－1A肾上腺素受体阻滞剂的α,w－二羧酰亚胺衍生物
CN1756753A (zh) 苯并呋喃衍生物
CN1053063A (zh) 喹唑啉衍生物及其制备方法
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication